BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25743577)

  • 1. Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase.
    Del Carlo S; Manera C; Chicca A; Arena C; Bertini S; Burgalassi S; Tampucci S; Gertsch J; Macchia M; Saccomanni G
    J Pharm Biomed Anal; 2015 Apr; 108():113-21. PubMed ID: 25743577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatography assay with fluorescence detection for the evaluation of inhibitors against human recombinant monoacylglycerol lipase.
    Holtfrerich A; Makharadze T; Lehr M
    Anal Biochem; 2010 Apr; 399(2):218-24. PubMed ID: 20015447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of a new fluorogenic substrate for monoacylglycerol lipase and application to inhibition studies.
    Lauria S; Casati S; Ciuffreda P
    Anal Bioanal Chem; 2015 Oct; 407(26):8163-7. PubMed ID: 26329281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
    Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
    Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorescence-based assay for monoacylglycerol lipase compatible with inhibitor screening.
    Wang Y; Chanda P; Jones PG; Kennedy JD
    Assay Drug Dev Technol; 2008 Jun; 6(3):387-93. PubMed ID: 18452392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a new reversible MAGL inhibitor.
    Tuccinardi T; Granchi C; Rizzolio F; Caligiuri I; Battistello V; Toffoli G; Minutolo F; Macchia M; Martinelli A
    Bioorg Med Chem; 2014 Jul; 22(13):3285-91. PubMed ID: 24853323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.
    Afzal O; Kumar S; Kumar R; Firoz A; Jaggi M; Bawa S
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3986-96. PubMed ID: 25011912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe.
    Miceli M; Casati S; Ottria R; Di Leo S; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).
    Granchi C; Caligiuri I; Minutolo F; Rizzolio F; Tuccinardi T
    Expert Opin Ther Pat; 2017 Dec; 27(12):1341-1351. PubMed ID: 29053063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
    Kapanda CN; Masquelier J; Labar G; Muccioli GG; Poupaert JH; Lambert DM
    J Med Chem; 2012 Jun; 55(12):5774-83. PubMed ID: 22651858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
    Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
    Granchi C; Bononi G; Ferrisi R; Gori E; Mantini G; Glasmacher S; Poli G; Palazzolo S; Caligiuri I; Rizzolio F; Canzonieri V; Perin T; Gertsch J; Sodi A; Giovannetti E; Macchia M; Minutolo F; Tuccinardi T; Chicca A
    Eur J Med Chem; 2021 Jan; 209():112857. PubMed ID: 33045662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.
    Granchi C; Caligiuri I; Bertelli E; Poli G; Rizzolio F; Macchia M; Martinelli A; Minutolo F; Tuccinardi T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1240-1252. PubMed ID: 28936880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.
    Ali MR; Kumar S; Shalmali N; Afzal O; Azim S; Chanana D; Alam O; Paudel YN; Sharma M; Bawa S
    Mini Rev Med Chem; 2019; 19(5):410-423. PubMed ID: 29962341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold.
    Bononi G; Tonarini G; Poli G; Barravecchia I; Caligiuri I; Macchia M; Rizzolio F; Demontis GC; Minutolo F; Granchi C; Tuccinardi T
    Eur J Med Chem; 2021 Nov; 223():113679. PubMed ID: 34218085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of monoacylglycerol lipase inhibitors.
    Mulvihill MM; Nomura DK
    Life Sci; 2013 Mar; 92(8-9):492-7. PubMed ID: 23142242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
    Aghazadeh Tabrizi M; Baraldi PG; Baraldi S; Ruggiero E; De Stefano L; Rizzolio F; Di Cesare Mannelli L; Ghelardini C; Chicca A; Lapillo M; Gertsch J; Manera C; Macchia M; Martinelli A; Granchi C; Minutolo F; Tuccinardi T
    J Med Chem; 2018 Feb; 61(3):1340-1354. PubMed ID: 29309142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present).
    Bononi G; Poli G; Rizzolio F; Tuccinardi T; Macchia M; Minutolo F; Granchi C
    Expert Opin Ther Pat; 2021 Feb; 31(2):153-168. PubMed ID: 33085920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study.
    Jha V; Biagi M; Spinelli V; Di Stefano M; Macchia M; Minutolo F; Granchi C; Poli G; Tuccinardi T
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.